4//SEC Filing
West Linda 4
Accession 0000899243-21-024505
CIK 0001563577other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 6:41 PM ET
Size
7.6 KB
Accession
0000899243-21-024505
Insider Transaction Report
Form 4
West Linda
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-16+9,888→ 9,888 totalExercise: $8.90Exp: 2031-06-15→ Common Stock (9,888 underlying) - Purchase
Common Stock
2021-06-15$9.13/sh+10,000$91,300→ 40,000 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.01 to $9.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]This option shall vest and become exercisable on the earlier of June 16, 2022 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date.
Documents
Issuer
Galera Therapeutics, Inc.
CIK 0001563577
Entity typeother
Related Parties
1- filerCIK 0001805257
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 6:41 PM ET
- Size
- 7.6 KB